Gary Krishnan

Gary Krishnan serves as the Chief Scientific Officer at Evozyne, bringing a wealth of experience from previous roles at Eli Lilly and Company, where Gary held significant positions including Vice President of Translational Research and Senior Research Fellow. Additionally, Gary previously occupied the role of Chief Scientific Officer at Eli Lilly and Company, demonstrating a strong background in scientific leadership and translational research within the pharmaceutical industry.